He Helped Create Modern AI. Now the ‘Godfather of AI’ Wants an FDA-Style Approval System for It.

According to a report by Entrepreneur, computer scientist Geoffrey Hinton, widely recognized as one of the pioneering figures or the "godfather of artificial intelligence," is calling for the creation of a regulatory framework for artificial intelligence modeled after the U.S. Food and Drug Administration. Hinton's proposal comes amid escalating concerns regarding the rapid development and deployment of highly advanced AI systems. The Nobel laureate suggests that tech companies should be required to secure formal government clearance before launching powerful new models to the public, establishing a standardized gateway to ensure safety and ethical compliance.

The proposed system would shift the burden of proof entirely to AI developers, the report indicates. Instead of deploying software first and addressing unintended consequences retroactively, companies would have to proactively demonstrate that their models meet rigorous safety thresholds. This evaluation process would likely involve testing for dangerous capabilities, such as the potential to facilitate cyber warfare, automate bio-threat generation, or bypass human control entirely. Under this model, an independent regulatory body would oversee these evaluations, ensuring that technology firms prioritize public safety over market speed.

This advocacy represents a significant evolution for Hinton, who spent decades advancing the neural networks that underpin modern generative AI before leaving Google to warn about its dangers. The Entrepreneur coverage highlights a growing consensus among some tech leaders and researchers that voluntary safety commitments are insufficient to mitigate the systemic risks posed by artificial general intelligence. Hinton has increasingly warned that the timeline for AI matching or exceeding human cognitive capabilities is shrinking rapidly, necessitating binding oversight.

However, establishing an approval agency for software faces significant practical hurdles. Unlike pharmaceutical drugs, which have long development cycles and predictable pathways, AI software evolves rapidly and can be easily modified post-release. Critics of hard regulation argue that a government-run approval process could stifle innovation, disadvantage smaller startups that lack compliance capital, and put domestic tech sectors at a competitive disadvantage globally, particularly against international rivals operating under fewer constraints.

For executives, founders, and leaders within the Valor & Ventures Media community, this debate marks a critical inflection point in the intersection of technology, national security, and governance. As AI becomes deeply integrated into business operations and national defense systems, the prospect of federal pre-market approval could reshape venture capital investment strategies and product development timelines. Understanding these regulatory headwinds is essential for leaders who must balance the rapid adoption of transformative technologies with the ethical and operational responsibilities of safeguarding their organizations and the public.